HUMA logo

HUMA
Humacyte Inc

8,136
Mkt Cap
$205.32M
Volume
1.1M
52W High
$2.93
52W Low
$0.5469
PE Ratio
-4.48
HUMA Fundamentals
Price
$0.8958
Prev Close
$0.9248
Open
$0.94
50D MA
$0.8751
Beta
2.24
Avg. Volume
4.66M
EPS (Annual)
-$0.2582
P/B
57.41
Rev/Employee
$11,076.09
$166.12
Loading...
Loading...
News
all
press releases
Humacyte, Inc. (HUMA) Surpasses Market Returns: Some Facts Worth Knowing
In the closing of the recent trading day, Humacyte, Inc. (HUMA) stood at $0.84, denoting a +2.66% move from the preceding trading day.
Zacks·5d ago
News Placeholder
More News
News Placeholder
Humacyte Highlights Dialysis Access Data; Women Show Strong ATEV Edge, V012 Results Due in June
Humacyte (NASDAQ:HUMA) outlined the unmet need in hemodialysis vascular access and highlighted data from its clinical program evaluating the company's acellular tissue engineered vessel (ATEV) as an...
MarketBeat·6d ago
News Placeholder
D. Boral Capital Reaffirms "Buy" Rating for Humacyte (NASDAQ:HUMA)
D. Boral Capital restated a "buy" rating and set a $25.00 target price on shares of Humacyte in a research note on Tuesday...
MarketBeat·7d ago
News Placeholder
BTIG Research Reaffirms Buy Rating for Humacyte (NASDAQ:HUMA)
BTIG Research reaffirmed a "buy" rating and set a $3.00 price target on shares of Humacyte in a research report on Tuesday...
MarketBeat·7d ago
News Placeholder
Humacyte Investigation Initiated: Kahn Swick & Foti, LLC Investigates the Officers and Directors of Humacyte, Inc. - HUMA
Humacyte Investigation Initiated: Kahn Swick & Foti, LLC Investigates the Officers and Directors of Humacyte, Inc. - HUMA Humacyte Investigation Initiated: Kahn Swick & Foti, LLC Investigates the...
PR Newswire·11d ago
News Placeholder
Humacyte, Inc. (HUMA) Stock Sinks As Market Gains: Here's Why
In the most recent trading session, Humacyte, Inc. (HUMA) closed at $0.7, indicating a -1.14% shift from the previous trading day.
Zacks·11d ago
News Placeholder
Humacyte (NASDAQ:HUMA) Earns "Buy" Rating from D. Boral Capital
D. Boral Capital restated a "buy" rating and issued a $25.00 price objective on shares of Humacyte in a research note on Tuesday...
MarketBeat·14d ago
News Placeholder
Humacyte, Inc. (HUMA) Stock Sinks As Market Gains: Here's Why
Humacyte, Inc. (HUMA) reached $0.68 at the closing of the latest trading day, reflecting a -7.13% change compared to its last close.
Zacks·19d ago
News Placeholder
Humacyte Investigation Initiated: Kahn Swick & Foti, LLC Investigates the Officers and Directors of Humacyte, Inc. - HUMA
Former Attorney General of Louisiana, Charles C. Foti, Jr., Esq., a partner at the law firm of Kahn Swick & Foti, LLC (KSF), announces that KSF has commenced an investigation into Humacyte, Inc. (NasdaqGS: HUMA) (Humacyte or the Company). On August 9, 2024, the company announced that the Food and...
Business Wire·22d ago
News Placeholder
Humacyte (NASDAQ:HUMA) Downgraded by Wall Street Zen to Strong Sell
Wall Street Zen downgraded shares of Humacyte from a "sell" rating to a "strong sell" rating in a research report on Saturday...
MarketBeat·24d ago
<
1
2
...
>

Latest HUMA News

View
Top Discussions

Advertisement|Remove ads.

Advertisement|Remove ads.